Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma
Clinical trial NCT03469934 · COMPLETED
Trial details
- NCT number
- NCT03469934
- Sponsor
- AnaptysBio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-14
- Primary completion
- 2018-10-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.